Background: Biomarker-driven molecular imaging has emerged as an integral part of cancer
precision radiotherapy. The use of molecular imaging probes, including nanoprobes, have …

Radiotherapy as a treatment method for glioblastoma is limited due to the intrinsic apoptosis
resistance mechanisms of the tumor. Administration of higher radiation doses contributes to …

Glioblastoma multiforme (GBM) remains incurable despite multimodal treatments after
surgical debulking. Almost all patients with GBM relapse within a narrow margin (2–3 cm) of …

Glioblastoma multiforme (GBM) is a highly aggressive brain tumor characterized by invasive
behavior and a compromised immune response, presenting treatment challenges. Surgical …

Accumulating evidence suggests that changes in the tumor microenvironment caused by
radiotherapy are closely related to the recurrence of glioma. However, the mechanisms by …

Background: Glioblastoma multiforme (GBM) is an aggressive brain tumour for which current
traditional treatment approaches have been unsuccessful, owing to the high genetic …

Glioblastoma (GBM) is characterized by an immunosuppressive tumor microenvironment
(TME) strictly associated with therapy resistance. Cyclooxygenase-2 (COX-2) fuels GBM …

Glioblastoma multiforme (GBM) is the most aggressive form of glioma and the most common
primary tumor of the central nervous system. Despite significant advances in clinical …

The emergence of resistance to prostate cancer (PCa) treatment, particularly to androgen
deprivation therapy (ADT), has posed a significant challenge in the field of PCa …

Background Glioblastomas are among the most malignant tumors which, despite aggressive
treatment, currently have an abysmal prognosis. These lesions are known to cause local …